Trial NCT04032158

View at ClinicalTrials.gov 
Org. Study IDs: MS200527_0073
Secondary IDs: 2018-004701-11

Last trial update was posted on 2021-08-05

MeSH Interventions

Interferon beta-1a

MeSH Conditions

Multiple Sclerosis Multiple Sclerosis, Relapsing-Remitting Sclerosis

Other Conditions

Relapsing-remitting Multiple Sclerosis

Stopping Reasons

Following analysis of open label extension (OLE) data from RMS phase 2 study (MS200527- 0086), it was determined that a change in active comparator warranted in phase 3 RMS comprised of trial MS200527-0073. Consequently, this trial terminated early.

Limitations And Caveats

Following analysis of open label extension (OLE) data from RMS phase 2 study (MS200527- 0086), it was determined that a change in active comparator warranted in phase 3 RMS comprised of trial MS200527-0073. Consequently, this trial terminated early, therefore, it was decided as per Statistical Analysis Plan not to report the efficacy data for this study.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID